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Introduction
Yawning is a common physiological event 
that occurs in humans, as well as in animals. 
It is not considered to be a simple reflex but 
rather a stereotyped event with unknown 
physiological functions. It is interesting to 
observe that fifty percent of  people yawn 
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after seeing someone else yawn. Even hear-
ing or reading about yawning may induce an-
other person to yawn. It is speculated that 
contagious yawning might be an innate ac-
tion that recognizes a particular behavioral 
state [1]. On another note, abnormal yawn-
ing has been observed in numerous patholo-
gies (neurological, psychiatric, iatrogenic, and 
infectious diseases) [2]).
Although there is a growing interest in 
the neurophysiology of  yawning, it remains 
somewhat of  a scientific mystery due to the 
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fact that we still do not know the exact mech-
anisms behind it. When discussing theories, 
the most common is that yawning compen-
sates oxygen deficiency in the blood [1]. Oth-
er theories consider yawning to be a ther-
moregulative mechanism that lowers brain 
temperature [1, 3], especially considering 
the fact that yawning has many physiological 
consequences that are consistent with those 
required for the regulation of  brain tempera-
ture.  It has been observed that several mental 
disorders affect brain thermoregulation, in-
cluding depressive and manic disorder. More 
specifically, brain temperature may rise in de-
pressive individuals and lower in patients suf-
fering from mania.  Furthermore, the major-
ity of  therapeutic strategies against mania are 
hypothermic, while those against depressive 
disorders are thermogenic [1]. Several neu-
rotransmitters and neuropeptides and their 
complex interplay represent another major 
point of  interest in the neurophysiology of  
yawning [4].
Many medicaments, including psycho-
pharmacs, can also cause severe and patho-
logical yawning. Yawning has been observed 
in some patients treated with the majority of  
novel serotonergic antidepressants, like esci-
talopram [1], paroxetine [5], venlafaxine [6, 
7], duloxetine [8], fluoxetine [9, 10], and ser-
traline [10, 11], as well as with tricyclic antide-
pressants like clomipramine and desipramine 
[10].
Case report
We will present the case of  a 42 year old 
woman, mother of  two children, who began 
treatment for a moderately severe depressive 
episode. Her psychic disturbances became 
apparent when she was still in high school, 
when she sought help from the school’s ther-
apist. She had been feeling “depressive” for 
years, but during the last year and a half  she 
became increasingly apathetic, indisposed, 
emotionally unstable and cried a lot. Based 
on these symptoms her general practitioner 
introduced the antidepressant paroxetine to 
the treatment, but prolactine levels increased 
soon afterwards [912.1] and led to the devel-
opment of  hyperprolactinemia, which in turn 
led to decreased libido and absence of  or-
gasm. Understandably, paroxetine was soon 
discontinued from treatment and she decided 
to seek psychiatric help.
In January 2012 she sought psychiatric 
help for the first time due to a three week 
long deterioration of  her psychological health 
which manifested as lowered mood, apathy 
and diminished energy and volition. The as-
sessment of  her psychological status showed 
a well kempt patient, without orientation and 
consciousness disturbances, spontaneous in 
contact although needing occasional assis-
tance, but crying during the whole interview. 
Psychomotor agitation was present. Her 
complexion was pale and her general mood 
was low. There were no formal thought dis-
turbances and the thought content was filled 
with depressive ideas from moral and health 
areas, her attention was hypovigilant and she 
presented hypertenacity of  attention without 
sensory delusions, with low vital dynamisms 
but no suicidal ideation. Mnestic functions 
and intelligence seemed unimpaired. Family 
history was negative for psychiatric disorders. 
Treatment was started with Sertraline at 25 
mg daily during the first two days, after which 
the dose was increased to 50 daily during 
the next three days and after the initial five 
days the dose was increased to 75 mg daily. 
Alprazolam at 0.25 mg was also introduced 
to treatment with a suggestion to use it only 
when really needed rather than regularly.
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At the follow-up psychiatric examination 
after two weeks the patient stated that cou-
ple of  days after sertraline introduction she 
started to yawn excessively, approximately 2 
to 3 times after 25 mg and 3 to 4 times after 
50 mg. She also complained that her “tem-
poromandibular joint is unable to close her 
mouth”. Sertraline was then discontinued, 
with her psychiatric status largely unchanged 
and disturbances still present. Tianeptine was 
then introduced at 12.5 mg daily during the 
first three days, after which the dose was in-
creased to 25 mg daily during the following 
three days and from then onwards to 37.5 mg 
daily, along with alprazolam when needed. 
We chose to slowly and cautiously adjust the 
dosage of  the newly introduced antidepres-
sant because the patient had developed side 
effects while treated with two different anti-
depressants.
At the control psychiatric examination af-
ter two weeks there were no apparent side ef-
fects of  tianeptine treatment and the patient’s 
psychical state improved significantly.
Discussion
Although we still do not know the exact 
mechanism behind yawning, we have already 
mentioned that several neurotransmitters and 
neuropeptides are thought to be involved in 
the neurophysiology of  yawning, especially 
dopamine, serotonin, acetylcholine, nitric ox-
ide, excitatory amino acids, oxytocin, opioid 
peptides, adrenocorticotropin, α-melanocyte 
stimulating hormone and related peptides. 
Involvement of  serotonin in the expression 
of  yawning is based on pharmacological ex-
periments showing that drugs which act se-
lectively on the 5-HT2C receptor subtype 
are extremely effective in inducing yawning 
when given systemically in rats, monkeys and 
humans [4]. 
We presented the case of  a female patient 
who developed excessive yawning when on 
small doses of  sertraline, and the increased 
dose lead to more frequent yawning that was 
bothersome for the patient. This is in accor-
dance with several other case reports on ser-
traline treatment. Reviewing the available lit-
erature we found a report of  a patient who 
had 75 to 100 yawning episodes daily follow-
ing a 1 to 2 week treatment with 50 mg of  
sertraline [10].
In this case, as well as in those already 
published, dose lowering and eventual dis-
continuation of  sertraline lead to cessation 
of  yawning episodes. Introduction of  an-
other antidepressant to the treatment did not 
cause the same side effect, mainly because 
medication with other pharmacologic prop-
erties was used [10]. 
Although described, sertraline induced ex-
cessive yawning is extremely rare and we still 
do not know why it occurs. Beside the already 
mentioned serotonin mechanism, one possi-
ble explanation would be the involvement of  
dopamine along with serotonin [4]. As it is 
known, sertraline acts as a dopamine reup-
take inhibitor, although in much higher doses 
than those that inhibit serotonin reuptake. As 
dopamine is also thought to have a significant 
role in the physiology of  yawning, we can 
only speculate on the possible mechanism of  
development of  yawning in this case. Further 
scientific research is necessary as all current 
theories on yawning are unable to completely 
clarify its physiology. 
Conclusion
Excessive yawning requires the same clini-
cal attention as the other side effects of  an-
tidepressant treatment and therefore should 
be carefully considered and managed. Intol-
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erance to antidepressant treatment is a sig-
nificant cause of  treatment failure and that 
is why psychiatrists should keep in mind that 
sertraline might cause such a disabling side 
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Prekomjerno zijevanje uzrokovano Sertralinom
Sažetak - Pozadina: Iako postoji sve veći znanstveni interes za istraživanjem neurofiziologije zijevanja, ono i 
dalje predstavlja znanstvenu zagonetku jer je točan mehanizam nastanka još uvijek nepoznat. Abnormalno 
i prekomjerno zijevanje se javlja u brojnih bolesti i poremećaja, no posebice u psihijatrijskih i neuroloških 
poremećaja, te kao nuspojava raznih medikamenata. Ispitanici: Prikazat ćemo slučaj četrdesetdvogodišnje 
žene kod koje je došlo do razvoja prekomjernog zijevanja kao nuspojave liječenja sertralinom. Rasprava: Iako 
su točni mehanizmi nastanka zijevanja još uvijek nepoznati, za nekoliko neurotransmitera i neuropeptida se 
smatra da igraju važnu ulogu u neurofiziologiji zijevanja, posebice monoamini serotonin i dopamin. U skladu 
s time, prekomjerno zijevanje je zabilježeno kao nuspojava u određenom broju bolesnika liječenih većinom 
novijih serotonergički aktivnih antidepresiva. Zaključak: Sam fenomen zijevanja, a posebice zijevanje kao po-
sljedica nuspojave liječenja antidepresivima, treba dobiti na značenju kao i druge nuspojave, te može biti 
predmetom proučavanja kako patofiziologije bolesti, tako i djelovanja drugih lijekova u ljudi.
Ključne riječi: prekomjerno zijevanje, sertralin, nuspojava, prikaz slučaja
